title: Stimulation by uraemic plasma of frusemide-sensitive sodium efflux in erythrocytes from normal women.
abstract: 1. Reduced Na+,K+ pump activity has been reported in uraemic erythrocytes, and this has been attributed to the presence of a circulating ouabain-like inhibitor. Since we have previously reported marked suppression of Na+,K+ co-transport activity in erythrocytes from dialysis patients, we have now examined the effect of incubation with uraemic plasma on Na+ efflux through the Na+,K+ pump and the co-transport pathway in normal erythrocytes from both men and women. 2. The results show that Na+ efflux via the Na+,K+ pump is not different between men and women (3.14 +/- 0.14 vs 3.68 +/- 0.18 mmol h-1 litre-1 of cells) and is not inhibited by incubation with uraemic plasma. 3. In contrast, co-transport-mediated Na+ efflux is lower in erythrocytes from normal women when compared with normal men (0.17 +/- 0.02 vs 0.25 +/- 0.05 mmol h-1 litre-1 of cells, P less than 0.001). 4. Moreover, incubation with uraemic plasma causes stimulation of Na+ efflux through the co-transport pathway in erythrocytes of healthy women (0.17 +/- 0.02 vs 0.27 +/- 0.03 mmol h-1 litre-1 of cells, P less than 0.005), but not in erythrocytes of healthy men (0.27 +/- 0.03 vs 0.25 +/- 0.05 mmol h-1 litre-1 of cells). 5. Our data do not support the presence of either a Na+,K+ pump or a co-transport inhibitor in plasma from dialysed uraemic patients. Thus, the suppressed co-transport activity demonstrated in uraemic erythrocytes cannot be attributed to a circulating inhibitor, and may reflect an acquired membrane or transport defect.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, Olive View Medical Center, Sylmar, California 91342-1495.
authors.forename: D B
authors.initials: DB
authors.lastname: Corry
authors.forename: M L
authors.initials: ML
authors.lastname: Tuck
authors.forename: D B
authors.initials: DB
authors.lastname: Lee
mesh_terms: D000328:Adult; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D005665:Furosemide / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D015221:Potassium Channels / Q000378:metabolism; D012964:Sodium / Q000032:analysis / Q000097:blood*; D015222:Sodium Channels / Q000378:metabolism; D014511:Uremia / Q000097:blood*
chemical_list: D015221:Potassium Channels; D015222:Sodium Channels; D005665:Furosemide; D012964:Sodium; D011188:Potassium